Oracle HNCUK´s Impact Statement

Oracle’s impact and delivery focus:

  • Engaging with Patients and Carers to support and guide them through the jargon and challenges in their cancer journeys by delivering and supporting campaigns to increase public knowledge of head and neck cancers. For example;
    • We publish a website that has an extensive “what to expect” guides for the various treatments and side effects that patients and caregivers will experience. Based on our research of the “key words” that people use in search engines, we´ve focused on head and neck cancer types and patient stories that users can better relate to through videos, articles and podcasts. We are now the 17th most visited source of information via google searches of head and neck cancer.
Where head and neck cancers occur
Just over half of patients with head and neck cancers are seen within the NHS target of 62 days.
Patients with head and neck cancers face the long delays.
  • We create and manage awareness campaigns to highlight what preventative and early diagnosis measures are available to reduce the numbers in future generations. Examples of this are;
  • Advancing research for better treatments and outcomes.
    • Over £10 million raised, 60+ research projects funded over last 15 years.
    • Leading force in ground-breaking advancements in important areas such as immunotherapy, combination treatments, surgical procedures, biomarker detections and speech recovery for patients.
    • Contributed to over 200 published research articles.
Patient in an ARC photon beam radiotherapy treatment
Patient undergoing photon beam radiotherapy treatment

One of few preventable cancers

Research funding disparity:

  • Head and Neck cancers only receive 1% of CRUK’s cancer-specific funding
  • Critical need for more investment in research to ensure these cancers are better understood and that treatments can ensure better quality of life outcomes.

Call to action:

  • We have a critical window of opportunity to change the trajectory of head and neck cancer in the UK.
  • Support and funding is needed for research, awareness, and improving patient outcomes.
  • To beat this crisis, we must continue to focus on:
    • Improving early diagnosis rates by increasing dental check-up visits and awareness generally
    • Increasing HPV vaccination take-up rates in the under 12 to 25 years old population.
    • Advancing and increased funding of research for better treatments and outcomes.
    • Collaborating with policymakers to reduce care disparities and “postcode lottery” in treatments.